US Patent 8106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
Patent 8106060 was granted and assigned to Boehringer Ingelheim on January, 2012 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8106060 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
